4 UK shares Fools think could be takeover targets

We’ve seen plenty of M&A activity in the UK markets already in 2024 — so which shares might be next in the firing line?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Here at The Motley Fool UK, we don’t just consider buying shares in companies because we think they will be snapped up in a takeover deal. We strive to identify high-quality businesses that are leaders in their sector, with shareholder-focused management.

But it is a reality that, from time to time, other firms’ leadership teams also see value in great companies and launch acquisition bids, resulting in a spike in the targeted firm’s share price.

With that in mind, here are a handful that could be considered as ripe for the picking!

Dr Martens 

What it does: Dr. Martens designs and sells iconic footwear around the globe.

Created with Highcharts 11.4.3Dr. Martens Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

By Ben McPoland. After losing around 82% of its value since going public in 2021, Dr Martens (LSE: DOCS) looks like a prime takeover target to me.

Its market cap is now just £755m, as I write. That seems low considering that the FTSE 250 bootmaker was valued at £3.7bn just three years ago.

The CEO is stepping down after sales have slowed and the firm issued its fifth profit warning in three years. Worryingly, there is ongoing weakness in its key North America market, where management says “it will take longer to see an improvement in USA results than initially anticipated.”

Some are now pushing for a strategic review. According to Reuters, one large shareholder recently wrote to the board to say: “Maintaining Dr Martens as an independent publicly traded company is likely no longer in the best interests of shareholders.

Despite the slump in sales, the company is still profitable and the brand remains strong in most global regions. So I reckon it’s just a matter of time before at least one bidder emerges.

Ben McPoland does not own shares in Dr Martens.  

ITV

What it does: ITV is the UK’s largest commercial broadcaster and operates a vast global production division.

Created with Highcharts 11.4.3ITV PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

By Royston Wild. ITV’s (LSE:ITV) share price has been under sustained pressure as weak advertising revenues have smacked profits. The former FTSE 100 broadcaster is down 7% over the past year, meaning over the last five years it has lost a whopping 45% of its value.

As a result, the company now trades on a rock-bottom forward price-to-earnings (P/E) ratio of 8.5 times. This is bound to attract the attention of a number of suitors.

The jewel in ITV’s crown is its sprawling production arm. ITV Studios — which is home to global hits like Love Island and The Voice — now accounts for 51% of group revenues.

And sales here are growing ahead of the market, up 4% to record levels in 2023. In an age when streaming companies are crying out for new content, ITV’s production prowess could make it a hot takeover target. Might the likes of Netflix or Amazon soon come calling?

Royston Wild does not own shares in any of the shares mentioned.

McBride

What it does: McBride makes own-label cleaning products. It also has a portfolio of brands including Surcare and Oven Pride.

Created with Highcharts 11.4.3McBride Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

By Stephen Wright. A good acquisition target needs three things. It needs an asset someone else wants to buy, it needs to be small enough to acquire, and it needs to be cheap enough to look like a bargain.

Cleaning products company McBride (LSE:MCB) has all three. The company’s valuable asset is its portfolio of brands, which includes Surcare and Oven Pride

With a market cap of £187m, it’s small enough to be an easy acquisition target for the likes of Unilever. Moreover, it could be a good addition to the FTSE 100 company’s existing product line.

The issue with price is a bit more complicated. At a price-to-earnings (P/E) ratio of 10, the stock looks like good value but not amazing value. 

Growth over the last decade has been pretty anaemic, which is why I wouldn’t buy the stock. But if a bigger company could energise sales and cut costs, it could be an interesting acquisition target.

Stephen Wright owns shares in Unilever

Smith & Nephew 

What it does: Smith & Nephew is a healthcare company that specialises in joint replacement technology and advanced wound management. 

Created with Highcharts 11.4.3Smith & Nephew Plc PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.co.uk

By Edward Sheldon, CFA. There are a lot of UK companies that I consider to be takeover targets right now. But one I want to highlight is medical technology business Smith & Nephew (LSE: SN.). 

There are several reasons I view this healthcare company as a potential takeover target. One is that it has a lot of long-term growth potential due to the world’s ageing population. So, established players in the medical device industry (like Johnson & Johnson or Stryker) might see an acquisition as a way to grow their revenues. 

Another is that it’s currently trading well below its highs at a very low valuation. At present, the price-to-earnings (P/E) ratio using the 2025 earnings forecast is just 11. That’s a low multiple for a high-quality healthcare business. 

Now, of course, we may not see any takeover action here in the years ahead. At the moment, the company is still recovering from Covid setbacks. 

However, it’s worth noting that in 2022, analysts at RBC named the company as one of their top UK takeover targets. So, I’m not the only one who sees the potential for an acquisition here. 

Edward Sheldon owns shares in Smith & Nephew. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool’s board of directors. The Motley Fool UK has recommended Amazon, ITV, Smith & Nephew Plc, and Unilever Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Could the S&P 500 be heading for an almighty crash?

Christopher Ruane shares his take on why he thinks the S&P 500 could be heading for a big fall at…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Down 64%, this FTSE 250 stock offers a 13% dividend yield for investors

This struggling investment banker has suffered significant losses in the past five years, but it has the second-highest yield on…

Read more »

Investing Articles

1 stock market ETF I’ve been buying during the sell-off

The stock market's been all over the place in April, creating a fertile breeding ground for long-term buying opportunities.

Read more »

Investing Articles

As the Sainsbury share price bucks the price-war trend on FY results, I examine the dividend prospects

The J Sainsbury share price has been regaining ground, despite growing fears of intense competition in the supermarket sector.

Read more »

The words "what's your plan for retirement" written on chalkboard on pavement somewhere in London
Investing Articles

Should I invest in a Stocks and Shares ISA or a SIPP to retire early?

Early retirement is the ultimate goal for many investors, but choosing between a Stocks and Shares ISA and a pension…

Read more »

Investing Articles

Is now a great time to consider buying Greggs shares?

Greggs shares have been hammered in 2025. But have they now fallen too far? Paul Summers takes another look at…

Read more »

Investing Articles

Is it still a great time to buy cheap shares as stock market crash fears recede?

Fear of a stock market crash can trigger panic selling... but that surely can't be the best thing to do…

Read more »

Hand of person putting wood cube block with word VALUE on wooden table
Investing Articles

The Vodafone share price is 24% undervalued, according to analysts

Our writer’s been looking at the latest targets for the Vodafone share price. Although there’s a wide variation, the average…

Read more »